Leng J. Chinese experts’ consensus on diagnosis and treatment of adenomyosis. Chin J Obstet Gynecol. 2020;55:376–83. https://doi.org/10.3760/cma.j.cn112141-20200228-00150.

Article  Google Scholar 

Xiong F, Li W, Rao X. Comparison of hysteroscopic electrotomy and curettagein the treatment of abnormal uterine bleeding caused byendometrial polyps. Contemp Med. 2021;27:88–90.

Google Scholar 

Chinese Obstetricians and Gynecologists Association; Cooperative Group of Endometriosis, Chinese Society of Obstetrics and Gynecology, Chinese Medical Association. Guideline for the diagnosis and treatment of endometriosis (third edition). Chin J Obstet Gynecol. 2021;56:812–24. https://doi.org/10.3760/cma.j.cn112141-20211018-00603.

Article  Google Scholar 

Gemzell-Danielsson K, Kubba A, Caetano C, Faustmann T, Lukkari-Lax E, Heikinheimo O. Thirty years of mirena: a story of innovation and change in women’s healthcare. Acta Obstet Gynecol Scand. 2021;100:614–8. https://doi.org/10.1111/aogs.14110.

Article  PubMed  Google Scholar 

Dason ES, Chan C, Sobel M. Diagnosis and treatment of adenomyosis. CMAJ: Can Med Association J = J de L’Association Medicale Canadienne. 2021;193:E242. https://doi.org/10.1016/j.jogc.2023.04.008.

Article  Google Scholar 

Kho KA, Chen JS, Halvorson LM. Diagnosis, evaluation, and treatment of adenomyosis. JAMA. 2021;326:177–8. https://doi.org/10.1001/jama.2020.26436.

Article  PubMed  Google Scholar 

Schrager S, Yogendran L, Marquez CM, Sadowski EA. Adenomyosis: diagnosis and management. Am Family Phys. 2022;105:33–8.

Google Scholar 

Li Q, Yuan M, Li N, Zhen Q, Chen C, Wang G. The efficacy of medical treatment for adenomyosis after adenomyomectomy. J Obstet Gynaecol Res. 2020;46:2092–9. https://doi.org/10.1111/jog.14376.

Article  PubMed  CAS  Google Scholar 

Fang H, Hong C, Gong X. Effects of Levonorgestrel combined with GnRH-a drug-assisted focused Ultrasound ablation on PI3K/PTEN signaling pathway in Adenomyosis. Clin Exp Obstet Gynecol. 2023;50. https://doi.org/10.31083/j.ceog5012269.

Tricco AC, Lillie E, Zarin W, O’Brien KK, Colquhoun H, Levac D, Moher D, Peters MDJ, Horsley T, Weeks L, et al. PRISMA Extension for scoping reviews (PRISMA-ScR): Checklist and Explanation. Ann Intern Med. 2018;169:467–73. https://doi.org/10.7326/M18-0850.

Article  PubMed  Google Scholar 

Higgins JPT, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, Savovic J, Schulz KF, Weeks L, Sterne JAC. The Cochrane collaboration’s tool for assessing risk of bias in randomised trials. BMJ (Clinical Res ed). 2011;343:d5928. https://doi.org/10.1136/bmj.d5928.

Article  Google Scholar 

Wells GA SB, O’Connell D, Peterson J, Welch V, Losos M et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Oxford 2000.

Fan L, Duan R, Fu Y. Effect of etonogesterone implant and levonorgestrel intrauterine system for treating patients with adenomyosis. Chin J Family Plann. 2022;30:279–83. https://doi.org/10.3969/j.issn.1004-8189.2022.02.007.

Article  Google Scholar 

Zhang L, Wang X. Influence of etonogestrel implant on improvement of pain relief and life quality in patients with adenomyosis. Chin J Clin Obstet Gynecol. 2023;24:487–9.

Google Scholar 

Xie B, Liu Y,Huang Y, Lu C. Analysis on clinical effect of etonogestrel subdermal implant in treatment of adeno-myosis. Maternal Child Health Care China. 2021;36:1708–11.

CAS  Google Scholar 

Wei A, Tang X, Yang W, Zhou J, Zhu W, Pan S. Efficacy of etonogestrel subcutaneous implants versus the levonorgestrel-releasing intrauterine system in the conservative treatment of adenomyosis. Open Med (Poland). 2024;19. https://doi.org/10.1515/med-2024-0914.

Ding H, Han Y. Impact on the sexual function of patients of three treatments for adenomyosis. Chin J Hum Sexuality. 2017;26:48–51. https://doi.org/10.3969/j.issn.1672-1993.2017.08.015.

Article  Google Scholar 

Zhao D, Zhang Y. Effects of different treatment methods on the quality of sexual life and marital life of patients with adenomy-osis. Chin J Hum Sexuality. 2016;25:43–6. https://doi.org/10.3969/j.issn.1672-1993.2016.06.014.

Article  Google Scholar 

Qin W, Liao J. Effects of Triptorelin acetate injection combined with levonorgestrel-releasing intra-uterine Systemon Uterine Hemodynamics,ovarian function and safety in patients with adenomyosis of Uterus. Evaluation Anal drug-use Hosp China. 2019;19:546–8. https://doi.org/10.14009/j.issn.1672-2124.2019.05.010.

Article  Google Scholar 

Wang L, Tang C. Influence of GnRH-αcombined with levonorgestrel intrauterine device system for treating women with adenomyosis on their pain symptoms, serum MMPs level, and recurrence rate. Chin J Family Plann. 2021;29:266–270274. https://doi.org/10.3969/j.issn.1004-8189.2021.02.014.

Article  CAS  Google Scholar 

Zhang Y. Application effect of GnRHa before placing levonorgestrel releasingintrauterine system on severe dysmenorrheaand menstrual volume plus adenomyosis. Anhui Med Pharm J. 2017;21:1311–3. https://doi.org/10.3969/j.issn.1009-6469.2017.07.039.

Article  Google Scholar 

Zhang D, Guo H, Qiu H. Effects of GnRH-α combined with mirena and serum recurrence related indicators in patients with adeno⁃myosis. J Practical Med. 2019;35:84–7. https://doi.org/10.3969/j.issn.1006-5725.2019.01.018.

Article  Google Scholar 

Guo M, Deng Z, Xu H. Clinical study of Mirena combined with gonadotropin-releasing hormone agonist inthe treatment of adenomyosis. J Guangxi Med Univ. 2020;37:506–9. https://doi.org/10.16190/j.cnki.45-1211/r.2020.03.031.

Article  CAS  Google Scholar 

Pang H, Chen J, Ruan Y. Clinical efficacy of GnRH-a combined with a levonorgestrel-releasing intrauterine system (Mirena) in patients with adenomyosis and its effects on ovarian function, CA125, CA153 and CEA expression. Chin J Prim Med Pharm. 2022;29:825–9. https://doi.org/10.3760/cma.j.issn.1008-6706.2022.06.006.

Article  Google Scholar 

Zhou Y, Wu X, Dong Q, Huang M. GnRH-a combined with levonorgestrel-releasing Intrauterine System in the treatment of large uterine adenomyosis. Chin J Minim Invasive Surg. 2013;13:1002–4.

Google Scholar 

Fang F, Liu S, Wang X, Lin X. Classified conservative treatment for adenomyosis:a preliminary observation. Shanghai Med J. 2015;38:239–44.

CAS  Google Scholar 

Li Q, Ding Y, Zhang X-Y, Feng W-W, Hua K-Q. Drug therapy for adenomyosis: a prospective, nonrandomized, parallel-controlled study. J Int Med Res. 2018;46:1855–65. https://doi.org/10.1177/0300060517752997.

Article  PubMed  PubMed Central  Google Scholar 

Wang X, Han X. Comparative study on treatment of adenomyosis with Adenomyotomy combined with Mirenaor GnRH-a. J Med Res. 2019;48:148–51.

Google Scholar 

Zhang C, Deng S. The effect observation of postoperative use of levonorgestrel slow releasing system in the vagina on adeno-myosis patients after laparoscopic uterus wedge resection. Chin J Hum Sexuality. 2018;27:106–8. https://doi.org/10.3969/j.issn.1672-1993.2018.04.033.

Article  Google Scholar 

ZhaoR, Wang L, Gu Y, Chen Y, Wei T, Wu N, Wang S. The efficacy of laparoscopic cytoreductive surgery with levonorgestrel releasing intra uterine system for the treatment of adenomyosis. Chin J Clin Obstet Gynecol. 2016;17:24–7. https://doi.org/10.13390/j.issn.1672-1861.2016.01.008.

Article  Google Scholar 

Li D, Xu Y, Shou J, Lin F, Zhang M, Shen Q. Observation of 53 cases of pain of adenomyosis treated with laparoscopic adenomyomectomy combined with the levonorgestrel releasing intra uterine system. Chin J Crit Care Medicine(Electronic Edition). 2010;3:331–4. https://doi.org/10.3877/cma.j.issn.1674-6880.2010.05.011.

Google Scholar 

Lei Q, Gong C, Li L, Xi F. Clinical analysis of uterine function reserved major uterinewall resection combined with mirena for severe adenomyosis. China J Mod Med. 2014;24:82–4.

Google Scholar 

Bi X, Ma J. The comprehensive application of conservative treatment for adenomyosis. J Chin Physician. 2021;23. https://doi.org/10.3760/cma.j.cn431274-20200504-00553.

Guo Q, Xu F, Ding Z, Li P, Wang X, Gao B. High intensity focused ultrasound treatment of adenomyosis: a comparative study. Int J Hyperthermia: Official J Eur Soc Hyperthermic Oncol North Am Hyperth Group. 2018;35:505–9. https://doi.org/10.1080/02656736.2018.1509238.

Article  CAS  Google Scholar 

Li X, Zhang Y, Chen J, Fang C. Efficacy of high intensity focused Ultrasound combined with GnRH-a and LNG-IUS in the treatment of Adenomyoma. J Clin Res. 2023;40:168–72. https://doi.org/10.3969/j.issn.1671-7171.2023.02.003.

Article  CAS  Google Scholar 

Wu Z, Pan Z, Lv X, Du Y, Jing M. Clinical observation of high-intensity focused ultrasound combined with levonorgestrel intrauterine sustained-release system in the treatment of adenomyosis. Shandong Med J. 2018;58:65–7. https://doi.org/10.3969/j.issn.1002-266X.2018.03.020.

Article  Google Scholar 

Yu L, Xu L. Effect of high intensity focused ultrasound combined with levonorgestrel releasing intrauterine system on serum CA 125, EMAb, hemoglobin and ovarian function in patients with adenomyosis. Chin J Family Plann Gynecotokology. 2019;11:33–6. https://doi.org/10.3969/j.issn.1674-4020.2019.04.10.

Article  CAS  Google Scholar 

Zhu H, Ma Q, Dong G, Yang L, Li Y, Song S, Mu Y. Clinical evaluation of high-intensity focused ultrasound ablation combined with mifepristone and levonorgestrel-releasing intrauterine system to treat symptomatic adenomyosis. Int J Hyperthermia: Official J Eur Soc Hyperthermic Oncol North Am Hyperth Group. 2023;40:2161641. https://doi.org/10.1080/02656736.2022.2161641.

Article  CAS  Google Scholar 

Xu Y, Zhou Z, Wang H, Shao L, Liu G. High-intensity focused Ultrasound Combined with Gonadotropin-releasing hormone agonist or levonorgestrel-releasing Intrauterine System in treating dysmenorrhea of severe adenomyosis. J Comput Assist Tomogr. 2021;45:224–31. https://doi.org/10.1097/RCT.0000000000001138.

Article  PubMed  Google Scholar 

Ye M, Deng X, Zhu X, Xue M. Clinical study of high intensity focused ultrasound ablation combined with GnRH-a and LNG-IUS for the treatment of adenomyosis. Chin J Obstet Gynecol. 2016;51:643–9.